1–4041

The bulk of the publications resulting from the SCANDAT collaboration can be found in transfusion journals, but we have also published papers in general internal medicine and oncology journals. For a complete listing, see below:

1.
Edgren G, Hjalgrim H, Rostgaard K, et al. Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients. J Intern Med. 2018;284(1):92-103. [PubMed]
2.
Just S, Rostgaard K, Titlestad K, et al. Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study. Ann Rheum Dis. March 2018. [PubMed]
3.
Zhao J, Rydén J, Wikman A, et al. Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010. Transfusion. 2018;58(2):390-401. [PubMed]
4.
Kreuger A, Rostgaard K, Middelburg R, et al. Storage time of platelet concentrates and risk of a positive blood culture: a nationwide cohort study. Transfusion. 2018;58(1):16-24. [PubMed]
5.
Edgren G, Hjalgrim H. Epidemiology of donors and recipients: lessons from the SCANDAT database. Transfus Med. November 2017. [PubMed]
6.
Ludvigsson J, Lebwohl B, Green P, Murray J, Hjalgrim H, Edgren G. Is Blood Transfusion Linked to Celiac Disease? A Nationwide Cohort Study. Am J Epidemiol. 2018;187(1):120-124. [PubMed]
7.
Edgren G, Ullum H, Rostgaard K, et al. Association of Donor Age and Sex With Survival of Patients Receiving Transfusions. JAMA Intern Med. 2017;177(6):854-860. [PubMed]
8.
Burgdorf K, Simonsen J, Sundby A, et al. Socio-demographic characteristics of Danish blood donors. PLoS One. 2017;12(2):e0169112. [PubMed]
9.
Ludvigsson J, Sjölander A, Murray J, Hjalgrim H, Edgren G. Haemoglobin decline before coeliac disease diagnosis: a nationwide transfusion cohort study of 1.1 million blood donors. Gut. 2017;66(11):2036-2037. [PubMed]
10.
Halmin M, Rostgaard K, Lee B, et al. Length of Storage of Red Blood Cells and Patient Survival After Blood Transfusion: A Binational Cohort Study. Ann Intern Med. 2017;166(4):248-256. [PubMed]
11.
Kotzé S, Pedersen O, Petersen M, et al. Deferral for low hemoglobin is not associated with increased risk of infection in Danish blood donors. Transfusion. 2017;57(3):571-577. [PubMed]
12.
Holzmann M, Sartipy U, Olsson M, Dickman P, Edgren G. Sex-Discordant Blood Transfusions and Survival After Cardiac Surgery: A Nationwide Cohort Study. Circulation. 2016;134(21):1692-1694. [PubMed]
13.
Grau K, Vasan S, Rostgaard K, et al. No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden. Transfusion. 2017;57(2):390-396. [PubMed]
14.
Vasan S, Hwang J, Rostgaard K, et al. ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors. Cancer Epidemiol. 2016;44:40-43. [PubMed]
15.
Edgren G, Hjalgrim H, Rostgaard K, et al. Transmission of Neurodegenerative Disorders Through Blood Transfusion: A Cohort Study. Ann Intern Med. 2016;165(5):316-324. [PubMed]
16.
Vasan S, Rostgaard K, Majeed A, et al. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors. Circulation. 2016;133(15):1449-57; discussion 1457. [PubMed]
17.
Halmin M, Chiesa F, Vasan S, et al. Epidemiology of Massive Transfusion: A Binational Study From Sweden and Denmark. Crit Care Med. 2016;44(3):468-477. [PubMed]
18.
Edgren G, Nyrén O, Hultcrantz M, et al. Blood donation and risk of polycythemia vera. Transfusion. 2016;56(6 Pt 2):1622-1627. [PubMed]
19.
Vasan S, Chiesa F, Rostgaard K, et al. Lack of association between blood donor age and survival of transfused patients. Blood. 2016;127(5):658-661. [PubMed]
20.
Sartipy U, Holzmann M, Hjalgrim H, Edgren G. Red Blood Cell Concentrate Storage and Survival After Cardiac Surgery. JAMA. 2015;314(15):1641-1643. [PubMed]
21.
Hjalgrim H, Rostgaard K, Vasan S, et al. No evidence of transmission of chronic lymphocytic leukemia through blood transfusion. Blood. 2015;126(17):2059-2061. [PubMed]
22.
Ullum H, Rostgaard K, Kamper-Jørgensen M, et al. Blood donation and blood donor mortality after adjustment for a healthy donor effect. Transfusion. 2015;55(10):2479-2485. [PubMed]
23.
Vasan S, Rostgaard K, Ullum H, Melbye M, Hjalgrim H, Edgren G. ABO Blood Group and Dementia Risk–A Scandinavian Record-Linkage Study. PLoS One. 2015;10(6):e0129115. [PubMed]
24.
Pedersen O, Axel S, Rostgaard K, et al. The heritability of blood donation: a population-based nationwide twin study. Transfusion. 2015;55(9):2169-74; quiz 2168. [PubMed]
25.
Edgren G, Rostgaard K, Vasan S, et al. The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion. 2015;55(7):1600-1606. [PubMed]
26.
Norda R, Andersson T, Edgren G, Nyren O, Reilly M. The impact of plasma preparations and their storage time on short-term posttransfusion mortality: a population-based study using the Scandinavian Donation and Transfusion database. J Trauma Acute Care Surg. 2012;72(4):954-960. [PubMed]
27.
Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280-1285. [PubMed]
28.
Edgren G, Hjalgrim H. Epidemiological considerations for the use of databases in transfusion research: a Scandinavian perspective. Curr Opin Hematol. 2010;17(6):596-601. [PubMed]
29.
Edgren G, Kamper-Jørgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010;50(6):1185-1195. [PubMed]
30.
Tynell E, Andersson T, Norda R, et al. Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002. Transfusion. 2010;50(6):1249-1256. [PubMed]
31.
Kamper-Jørgensen M, Hjalgrim H, Edgren G, et al. Expensive blood safety initiatives may offer less benefit than we think. Transfusion. 2010;50(1):240-242. [PubMed]
32.
Shanwell A, Andersson T, Rostgaard K, et al. Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang. 2009;96(4):316-323. [PubMed]
33.
Kamper-Jørgensen M, Edgren G, Rostgaard K, et al. Blood transfusion exposure in Denmark and Sweden. Transfusion. 2009;49(5):888-894. [PubMed]
34.
Kamper-Jørgensen M, Ahlgren M, Rostgaard K, et al. Survival after blood transfusion. Transfusion. 2008;48(12):2577-2584. [PubMed]
35.
Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008;100(8):572-579. [PubMed]
36.
Edgren G, Tran T, Hjalgrim H, et al. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion. 2007;47(11):2017-2024. [PubMed]
37.
Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007;369(9574):1724-1730. [PubMed]
38.
Edgren G, Hjalgrim H, Tran T, et al. A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang. 2006;91(4):316-323. [PubMed]
39.
Edgren G, Bagnardi V, Bellocco R, et al. Pattern of declining hemoglobin concentration before cancer diagnosis. Int J Cancer. 2010;127(6):1429-1436. [PubMed]
40.
Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst. 2007;99(24):1864-1874. [PubMed]
41.
Edgren G, Murphy E, Brambilla D, et al. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. JAMA. 2019;321(22):2183-2192. [PubMed]